PLASOMA Ultimate Safety & Efficacy Study (PULSE)
Sponsor: Diabetes Fonds
Listed as NCT04828304, this NA trial focuses on Burn Wound and Diabetic Foot Ulcer and remains completed. Sponsored by Diabetes Fonds, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Jan 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2021 — Sep 2022 [monthly]
Recruiting NA
-
May 2021 — Jun 2021 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Diabetes Fonds
- Pathology and Medical Microbiology
- Plasmacure
For direct contact, visit the study record on ClinicalTrials.gov .